TGF-β1 induces the formation of vascular-like structures in embryoid bodies derived from human embryonic stem cells

Experimental and Therapeutic Medicine

Volumn 8, Issue 1, 2014, Pages 52-58

  Wang, Yan ^a   Qian, De Jian ^a   Zhong, Wen Yu ^b   Lu, Jun Hong ^c   Guo, Xiang Kai ^a   Cao, Yi Lin ^c   Liu, Ju ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Embryoid body; Endothelial cell; Human embryonic stem cell; Transforming growth factor

Indexed keywords

CD31 ANTIGEN; FETAL LIVER KINASE 1; PEPTIDES AND PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL RENEWAL; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EMBRYOID BODY; EMBRYONIC STEM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; POLYMERASE CHAIN REACTION; RNA ISOLATION; SCANNING ELECTRON MICROSCOPY; VASCULARIZATION;

EID: 84901365406     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1721     Document Type: Article

References (44)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al: Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998.
2. Irion S, Nostro MC, Kattman SJ and Keller GM: Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications. Cold Spring Harb Symp Quant Biol 73: 101-110, 2008.
3. Murry CE and Keller G: Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132: 661-680, 2008.
4. Murry CE, Reinecke H and Pabon LM: Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 47: 1777-1785, 2006.
5. Freund C and Mummery CL: Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 107: 592-599, 2009.
6. Avery S, Zafarana G, Gokhale PJ and Andrews PW: The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells 28: 863-873, 2010.
7. Poon E, Clermont F, Firpo MT and Akhurst RJ: TGFbeta inhibition of yolk-sac-like differentiation of human embryonic stem-cell-derived embryoid bodies illustrates differences between early mouse and human development. J Cell Sci 119: 759-768, 2006.
8. Massagué J and Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19: 1745-1754, 2000.
9. Doetschman T, Shull M, Kier A and Coffin JD: Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders. Hypertension 22: 618-629, 1993.
10. Shull MM, Ormsby I, Kier AB, et al: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699, 1992.
11. Oshima M, Oshima H and Taketo MM: TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179: 297-302, 1996.
12. Vallier L, Alexander M and Pedersen RA: Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118: 4495-4509, 2005.
13. Besser D: Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 279: 45076-45084, 2004.
14. James D, Levine AJ, Besser D and Hemmati-Brivanlou A: TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132: 1273-1282, 2005.
15. Ng YS, Ramsauer M, Loureiro RM and D'Amore PA: Identification of genes involved in VEGF-mediated vascular morphogenesis using embryonic stem cell-derived cystic embryoid bodies. Lab Invest 84: 1209-1218, 2004.
16. Gendron RL, Tsai FY, Paradis H and Arceci RJ: Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo. Dev Biol 177: 332-346, 1996.
17. Hirashima M, Kataoka H, Nishikawa S, et al: Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 93: 1253-1263, 1999.
18. Goumans MJ, Zwijsen A, van Rooijen MA, et al: Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development 126: 3473-3483, 1999.
19. Zhang XJ, Tsung HC, Caen JP, Li XL, Yao Z and Han ZC: Vasculogenesis from embryonic bodies of murine embryonic stem cells transfected by Tgf-beta1 gene. Endothelium 6: 95-106, 1998.
20. Zhang WJ and Cao YL: Stem cell, the basis for tissue and organ reconstruction. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27: 662-664, 2005(In Chinese).
21. Wu CF, Tsung HC, Zhang WJ, et al: Improved cryopreservation of human embryonic stem cells with trehalose. Reprod Biomed Online 11: 733-739, 2005.
22. Wall RT, Counts RB, Harker LA and Striker GE: Binding and release of factor VIII/von Willebrand's factor by human endothelial cells. Br J Haematol 46: 287-298, 1980.
23. Dahéron L, Opitz SL, Zaehres H, et al: LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22: 770-778, 2004.
24. Bendall SC, Stewart MH, Menendez P, et al: IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448: 1015-1021, 2007.
25. Lee JS, Seo TW, Yi JH, et al: CHIP has a protective role against oxidative stress-induced cell death through specific regulation of endonuclease G. Cell Death Dis 4: e666, 2013.
26. Shibuya M: Tyrosine kinase receptor Flt/VEGFR family: Its characterization related to angiogenesis and cancer. Genes Cancer 1: 1119-1123, 2010.
27. Jeon SH, Chae BC, Kim HA, et al: Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81: 557-566, 2007.
28. Leibovich SJ and Wiseman DM: Macrophages, wound repair and angiogenesis. Prog Clin Biol Res 266: 131-145, 1988.
29. Park C, Kim TM and Malik AB: Transcriptional regulation of endothelial cell and vascular development. Circ Res 112: 1380-1400, 2013.
30. Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167-4171, 1986.
31. Carmeliet P, Ferreira V, Breier G, et al: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996.
32. Baird A and Durkin T: Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun 138: 476-482, 1986.
33. Heimark RL, Twardzik DR and Schwartz SM: Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233: 1078-1080, 1986.
34. Maharaj AS, Saint-Geniez M, Maldonado AE and D'Amore PA: Vascular endothelial growth factor localization in the adult. Am J Pathol 168: 639-648, 2006.
35. Ferrara N and Bunting S: Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens 5: 35-44, 1996.
36. Ingber DE, Madri JA and Jamieson JD: Role of basal lamina in neoplastic disorganization of tissue architecture. Proc Natl Acad Sci USA 78: 3901-3905, 1981.
37. Merwin JR, Anderson JM, Kocher O, Van Itallie CM and Madri JA: Transforming growth factor beta 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 142: 117-128, 1990.
38. Cavallaro U, Liebner S and Dejana E: Endothelial cadherins and tumor angiogenesis. Exp Cell Res 312: 659-667, 2006.
39. Lammert E and Axnick J: Vascular lumen formation. Cold Spring Harb Perspect Med 2: a006619, 2012.
40. Lampugnani MG, Orsenigo F, Rudini N, et al: CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 123: 1073-1080, 2010.
41. Strilić B, Kucera T, Eglinger J, et al: The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 17: 505-515, 2009.
42. Cook BD, Ferrari G, Pintucci G and Mignatti P: TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling. J Cell Biochem 105: 1367-1373, 2008.
43. Mignone JL, Kreutziger KL, Paige SL and Murry CE: Cardiogenesis from human embryonic stem cells. Circ J 74: 2517-2526, 2010.
44. Goumans MJ, de Boer TP, Smits AM, et al: TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 1: 138-149, 2007.